Phase
Condition
Diabetes And Hypertension
Diabetes Prevention
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient with type 2 diabetes defined by (HAS 2013):
a blood glucose level above 1.26 g / l (7.0 mmol / l) after an 8-hour fast andchecked twice;
or the presence of symptoms of diabetes (polyuria, polydipsia, weight loss)associated with blood glucose (on venous plasma) greater than or equal to 2 g / l (11.1 mmol / l);
or blood glucose (on venous plasma) greater than or equal to 2 g / l (11.1 mmol /l) 2 hours after an oral load of 75 g of glucose (criteria proposed by the WorldHealth Organization).
Patient with HbA1c at inclusion> 7 and <12% (on an HbA1c dose less than 6 months oldat the prescreening)
Patient with a BMI ≥ 25 and a weight ≤ 125 kg
Patient with appropriate treatment
Age ≥ 18 years
Available to go on treatment in 6 weeks after inclusion
Available for a 12-month follow-up
Affiliated to the social security or beneficiary of such a scheme
Exclusion
Exclusion Criteria:
Diabetes type 1 or secondary
Patient with GFR (glomerular filtration rate) <50 ml / min (MDRD formulation) for atleast 1 year.
Unstable diabetes defined by the knowledge of the questioning of a change in HbA1c of +/- 1 in the last 6 months.
With known serious comorbidity and / or limited life expectancy (<5 years), or withadvanced macrovascular complications: in particular cardiovascular (acute coronarydiseases and / or stroke in the last 6 months) and renal
Severe psychiatric pathology or psychosis
Pregnant woman, parturient or breastfeeding
Contraindication to hydrotherapy
Patient with a contraindication to moderate physical activity or cycling (acutecoronary artery disease less than 2 years old, musculoskeletal problem of the spine orlower limbs incompatible with cycling).
No previous spa treatment for "Digestive disorders and metabolic diseases" in thecurrent the spa year.
Person deprived of liberty or legal protection measure
Subject participating to an other clinical study interventional.
Study Design
Study Description
Connect with a study center
ROUSSEL Ludivine
Amiens,
FranceSite Not Available
SOUDET Simon
Amiens,
FranceSite Not Available
ODDOU Christel
Annecy,
FranceSite Not Available
CLERGEOT Annie
Besançon,
FranceSite Not Available
WATERLOT
Chambéry,
FranceSite Not Available
PRUILHERE Sylvie
Clermont-Ferrand,
FranceSite Not Available
DAOUDI
Corbeil-Essonnes,
FranceSite Not Available
PENFORNIS Alfred
Corbeil-Essonnes,
FranceSite Not Available
BETRY Cécile
Grenoble,
FranceSite Not Available
PARADIS Sabrina
Montmélian,
FranceActive - Recruiting
POPELIER Marc
Paris,
FranceSite Not Available
APRILE Sophie
Vals-les-Bains,
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.